Dr. Brian Kennedy, CEO of Buck Institute for Research on Aging joins the Launching Longevity: Funding the Fountain of Youth panel on June 21, 2016. Kennedy has years of teaching experience as well as being published in over 80 prestigious journals.
Kennedy holds a Ph.D. in Biology from MIT and is well known for his work with Leonard Guarente Ph.D., which led to the discovery that Sirtuins modulate aging. After completing his Ph.D., Kennedy began teaching Biochemistry at the University of Washington in Seattle. Kennedy became CEO of the Buck Institute for Research on Aging in 2010.
Kennedy is currently focusing on research on cardiovascular disease, metabolic syndromes, genetic mutations and the target of rapamycin pathway (TOR). Recently his research showed that mice lifespans can be extended. This research is leading the lab closer to understanding diseases of aging, and how to extend a humans longevity.
The Buck Institute is the nation’s first independent research facility focused solely on understanding the connection between aging and chronic disease. At the Buck Institute, world-class scientists work in a uniquely collaborative environment to understand how normal aging contributes to the development of conditions specifically associated with getting older.
Launching Longevity: Funding, the Fountain of Youth, is an event you won’t want to miss. Our panelists all have different levels of expertise and experience in the Longevity field. Find out how human longevity will impact future generations. Hear what thoughts Kennedy has to share on June 21, 2016, at SRI International.